MYCN and neuroblastoma: Increased NME1 gene copy number has been directly identified in 14%–23% of neuroblastoma tumors [43,44], and increased NME1 expression has also been identified in high-risk neuroblastoma tumors [43,44,45,46,47], possibly secondary to MYCN-mediated regulation of NME1 expression [48].